MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results

NEXT STORY
Calithera Biosciences to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
PREV STORY
American Board of Medical Specialties Announces New Standards for Continuing Certification
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Prolaris® Test Identifies Men with Prostate Cancer Who Can Safely Defer Treatment

author_avatar
NASDAQ Market News

Wesana Health Partners with University of South Carolina

author_avatar
NASDAQ Market News

Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients

author_avatar
NASDAQ Market News